Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 375 entries
View as:

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Phase: N/A Priority: Normal
NCT ID: NCT01530997 Org: User:
Start: 02/07/12 End: 11/30/19 Due: 11/30/20

Abequolixron (RGX-104) and Durvalumab in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05911308 Org: User:
Start: 04/01/24 End: 02/27/25 Due: 02/27/26

The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02574897 Org: User:
Start: 07/31/14 End: 09/30/17 Due: 09/30/18

Reverse Axillary Mapping in Breast Radiation Treatment Planning

Phase: N/A Priority: Normal
NCT ID: NCT04292860 Org: User:
Start: 05/31/21 End: 01/31/27 Due: 01/31/28

Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease

Phase: N/A Priority: Normal
NCT ID: NCT02781025 Org: User:
Start: 04/30/16 End: 12/30/20 Due: 12/30/21

BREAST Choice Decision Tool R21

Phase: N/A Priority: Normal
NCT ID: NCT06817226 Org: User:
Start: 10/10/24 End: 08/31/25 Due: 08/31/26

Multimedia Aid Gynecologic Counseling and Consent

Phase: N/A Priority: Normal
NCT ID: NCT03899441 Org: User:
Start: 10/01/18 End: 04/01/20 Due: 04/01/21

Physical Activity Centers Empowerment

Phase: N/A Priority: Normal
NCT ID: NCT06411756 Org: User:
Start: 08/14/24 End: 12/15/25 Due: 12/15/26

A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium

Phase: N/A Priority: Normal
NCT ID: NCT02767362 Org: User:
Start: 11/30/15 End: 09/26/19 Due: 09/26/20

Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03161834 Org: User:
Start: 01/13/17 End: 07/09/20 Due: 07/09/21

Fitness in Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02564458 Org: User:
Start: 09/30/15 End: 06/30/18 Due: 06/30/19

Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian

Phase: N/A Priority: Normal
NCT ID: NCT04670068 Org: User:
Start: 01/27/21 End: 02/28/30 Due: 02/28/31

Virtual Testis Cancer Lay Support and Survivorship Aim 2

Phase: N/A Priority: Normal
NCT ID: NCT06702592 Org: User:
Start: 06/30/25 End: 06/30/28 Due: 06/30/29

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03672396 Org: User:
Start: 04/01/17 End: 12/31/19 Due: 12/31/20

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Phase: N/A Priority: Normal
NCT ID: NCT03602157 Org: User:
Start: 12/12/18 End: 09/30/41 Due: 09/30/42

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02276560 Org: User:
Start: 01/31/15 End: 06/30/16 Due: 06/30/17

Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01789983 Org: User:
Start: 10/31/12 End: 12/31/21 Due: 12/31/22

Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02449837 Org: User:
Start: 05/31/14 End: 02/20/22 Due: 02/20/23

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Phase: N/A Priority: Normal
NCT ID: NCT05366179 Org: User:
Start: 09/02/22 End: 05/30/30 Due: 05/30/31

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00233974 Org: User:
Start: 05/31/02 End: 03/31/06 Due: 03/31/07

Physical Function During ARSI Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05612880 Org: User:
Start: 10/13/22 End: 11/06/24 Due: 11/06/25

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Phase: N/A Priority: Normal
NCT ID: NCT06296368 Org: User:
Start: 06/21/24 End: 09/01/28 Due: 09/01/29

3-D Super Resolution Ultrasound Microvascular Imaging

Phase: N/A Priority: Normal
NCT ID: NCT04136912 Org: User:
Start: 05/26/22 End: 02/15/26 Due: 02/15/27

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets

Phase: N/A Priority: Normal
NCT ID: NCT04073966 Org: User:
Start: 12/04/19 End: 09/15/26 Due: 09/15/27

Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02577939 Org: User:
Start: 06/30/13 End: 06/30/15 Due: 06/30/16